Clinical Trial Update: Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 clinical trial of AVI-4065 in healthy volunteers and patients with chronic active Hepatitis C was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• AVI-4065

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: TERMINATED